Vaccines by six developers – Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute) – are the ones doing the rounds in the region. Here’s what’s known about them.
The use of realistic health record information that mimics lifelong medical histories can enable more innovative algorithms for disease modeling.
New features include enhanced security with Microsoft Azure Key Vault and Istio Service Mesh and scalable storage for EHR documents, images and DNA sequence files.
AI-powered clinical decision support enables clinicians in improving quality of care by reducing unwarranted variations.
Also, a £10 million research investment made in early stage cancer detection.
The partnership will use de-identified patient data to zero in on factors that worsen COVID-19 outcomes among certain groups.
S4S pilot project participants noted that research requirements can affect the ability to adopt third-party apps, among other barriers to broader adoption of patient-directed data sharing.
Both will work together to accelerate the growth of transformational healthcare companies across markets in the Middle East and North African, and the Association of South-East Asian Nations.
Working with AWS, researchers from UPMC, the University of Pittsburgh, and Carnegie Mellon are building new machine learning tools for breast cancer and depression screening.
Measuring and managing Multiple Sclerosis: could digital assessment tools improve our understanding?
The extent to which the world of digital health has changed during the COVID-19 pandemic has been widely recognised.